SCHEMBL12697232

SCHEMBL12697232

CC[C@H](C)Nc1ccc(C)nc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.61
ALDH1A1 P00352 1/20 0.61
HSP90AA1 P07900 1/20 0.61
CYP3A4 P08684 1/20 0.61
THRB P10828 1/20 0.61
ALOX15 P16050 1/20 0.61
TSHR P16473 1/20 0.61
CASP1 P29466 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
HIF1A Q16665 1/20 0.61
HSD17B10 Q99714 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
L3MBTL1 Q9Y468 1/20 0.61
HCAR3 P49019 1/20 0.41
LRRK2 Q5S007 1/20 0.38
NPSR1 Q6W5P4 1/20 0.36
SORT1 Q99523 1/20 0.35
KCNQ3 O43525 1/20 0.35
KCNQ2 O43526 1/20 0.35
MAPK14 Q16539 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12697206 0.80 TDP1 (0.43) ALDH1A1CYP3A4THRBALOX15TSHR
SCHEMBL7865565 0.80 L3MBTL1 (0.59) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL12695048 0.80 TP53 (0.59) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL12695051 0.80 TP53 (0.59) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL17461800 0.80 ALDH1A1 (0.59) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL21276075 0.80 ALDH1A1 (0.59) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL30797253 0.78 NPSR1 (0.40) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL49805 0.77 ALDH1A1 (1.00) TP53ALDH1A1HSP90AA1CYP3A4THRB
SCHEMBL15223665 0.77 NPSR1 (0.41) ALDH1A1SMN1; SMN2NPSR1SORT1KCNQ3
SCHEMBL5069800 0.76 HDAC1 (0.38) ALDH1A1SMN1; SMN2NPSR1SORT1KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120245136-A1 CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2012-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120245136-A1 CHROMAN-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS KCNJ2, KCNJ1, KCNC1 TP53 4066/4885ALDH1A1 1764/4885HSP90AA1 1131/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.